FDA Orange Book Archives
Approved Drug Products With Therapeutic Equivalance Evaluations In addition to its deep database of global drug and patent information, DrugPatentWatch […]
Featured, Talks and Publications
General Biotechnology
How Microbiotics is Shaping the Health Industry
This is a guest post from Jeriann Watkins at . Do you have a response to Jeriann’s post? Respond in
Process Validation and Its Need in the Biotechnology Industry
This is a guest post from Edward Simpson, a seasoned calibration and technical engineer. Do you have a response to
Process Validation and Its Need in the Biotechnology Industry Read Post »
General Biotechnology, Guest content
Making sense of drug names
This is a guest post from DrugPatentWatch. Do you have a response to DrugPatentWatch’s post? Respond in the comments section below.
General Biotechnology, Guest content
Formulary Best Practice: Cost Containment through Generic Drugs
This is a guest post from DrugPatentWatch. Do you have a response to DrugPatentWatch’s post? Respond in the comments section below.
Formulary Best Practice: Cost Containment through Generic Drugs Read Post »
General Biotechnology
Where are drugs invented? Globalization in the pharmaceutical industry
This is a guest post from DrugPatentWatch. Do you have a response to DrugPatentWatch’s post? Respond in the comments section below.
Where are drugs invented? Globalization in the pharmaceutical industry Read Post »
Believing in Unicorns…and Valuing Them
This is a guest post from Rajan Pragani, an FDA scientist, as part of his final project the the NIH’s
Journal of Commercial Biotechnology New Issue Published
The latest issue of the Journal of Commercial Biotechnology is now available. Check out the Table of Contents below, and
Journal of Commercial Biotechnology New Issue Published Read Post »
Branding Biotech – Communicating the Brand’s Point of Differentiation
This is a guest post from Brannon Cashion, President of Addison Whitney Health. Do you have a response to Brannin’s post?
Branding Biotech – Communicating the Brand’s Point of Differentiation Read Post »
Will Brexit Actually Happen?
Following two posts on Brexit and British biotechnology, I would like to provide a perspective that turns everything on its
